GSK pledges $30bn US investment as UK's pharma woes deepen
Source: BBC
British pharmaceutical firm GSK has pledged to invest $30bn (£22bn) in research and manufacturing in the US over the next five years.Announced at the start of US President Donald Trump's visit to the UK, the money will fund the development of next-generation factories, artificial intelligence (AI) and research labs in the US, said GSK.British Prime Minister Sir Keir Starmer said the investment was a "powerful…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at BBC